↓ Skip to main content

Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis

Overview of attention for article published in Frontiers in endocrinology, December 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
28 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis
Published in
Frontiers in endocrinology, December 2022
DOI 10.3389/fendo.2022.1078686
Pubmed ID
Authors

Xuefeng Li, Hongli Wu, Huifang Peng, Hongwei Jiang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 28 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 11%
Student > Bachelor 1 4%
Lecturer 1 4%
Lecturer > Senior Lecturer 1 4%
Student > Master 1 4%
Other 0 0%
Unknown 21 75%
Readers by discipline Count As %
Medicine and Dentistry 4 14%
Unspecified 3 11%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Unknown 20 71%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 August 2023.
All research outputs
#8,612,358
of 26,246,850 outputs
Outputs from Frontiers in endocrinology
#2,625
of 13,403 outputs
Outputs of similar age
#162,266
of 493,960 outputs
Outputs of similar age from Frontiers in endocrinology
#147
of 986 outputs
Altmetric has tracked 26,246,850 research outputs across all sources so far. This one has received more attention than most of these and is in the 66th percentile.
So far Altmetric has tracked 13,403 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 493,960 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 986 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.